1 not yet recruiting, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow Metabolic Dysfunction-Associated Steatohepatitis (MASH): new trials by email Literature Review of Metabolic Dysfunction-Associated Steatohepatitis (MASH) trials Research Report on Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nutrition Intervention Combined With Resmetirom for MASH Resmetirom therapy, Comprehensive nutritional intervention, Standard dietary support - Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Phase 4 | Not yet recruiting | City University of New York | 120 | 2026-10-01 | 2026-07-06 |
| Fibrosis Lessens After Metabolic Surgery Metabolic surgery, Incretin-Based Therapy - Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease | Phase 4 | Recruiting | The Cleveland Clinic | 120 | 2024-07-11 | 2026-07-31 |
Liver Cirrhosis (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1)
Body Weight (1) · Digestive System Diseases (1) · Fatty Liver (1) · Fibrosis (1) · Liver Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Overweight (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Bariatric Surgery (1) · Gastric Bypass (1)
City University of New York (1) · The Cleveland Clinic (1)
United States (2) · Brazil (1) · Canada (1) · Finland (1) · India (1) · Ireland (1) · Italy (1) · Kuwait (1) · Mexico (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Ali Aminian, MD (1)